Slate Medicines has secured a $130m Series A financing round aimed at advancing anti-PACAP migraine therapies.
Children are protected against fewer diseases as per the new schedule, which the states say will damage public health.
NorthX Biologics and Demeetra have entered a strategic partnership focused on integrated CLD and GMP manufacturing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results